A mom who was diagnosed with stage four cervical cancer claims doctors said her blood clot symptoms were “just your period.” ...

Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

More than one million people are receiving between £28.70 and £184.30 each week through PIP or Adult Disability Payment for ...

For patients with human papillomavirus (HPV) type 16 (HPV16)-positive cervical intraepithelial neoplasia grade 3 (CIN3), vaccination with a replication-incompetent Semliki Forest virus vaccine ...

Are you interested in receiving a Prevent Cancer Foundation research grant? Applications for 2026 grants will open in the ...

Press Release - Researchers led by the Africa Centers for Disease Control (Africa CDC) will establish three Centers of Excellence in Rwanda, Morocco, and Zambia to gather evidence and accelerate ...

Y. Hou, MD Cervical cancer is one of the most preventable and treatable cancers, thanks to the HPV vaccine and regular ...

Bhubaneswar: One in three men and one in nine women are suffering from oral cancer in Khurda district, including the state ...

Precigen has a market cap of $468mn and a cash runway into 2026, but needs more funds for commercialization. Check out my ...

A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...